This inventor holds 2 USPTO granted patents. Top assignee: Teijin Pharma Limited. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Hitoshi Wada: Innovator in Protein Research
Introduction
Hitoshi Wada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of protein research, particularly in the development of novel polypeptides. With a total of 2 patents to his name, Wada's work focuses on innovative solutions for medical applications.
Latest Patents
Wada's latest patents include a groundbreaking invention related to a polypeptide that exhibits activities of inhibiting angiogenesis and osteoclastogenesis. The aim of this invention is to provide a recombinant protein that can be purified effectively. This protein is intended to serve as an ingredient in the design of remedies for various conditions, including tendinitis, rheumatoid arthritis, arthritis deformans, and malignant tumors. The novel soluble polypeptide protein represents a significant advancement in therapeutic options.
Career Highlights
Hitoshi Wada is currently associated with Teijin Pharma Limited, where he continues to push the boundaries of protein research. His work has garnered attention for its potential impact on treating serious medical conditions. Wada's dedication to innovation in this field is evident through his ongoing research and development efforts.
Collaborations
Wada collaborates with esteemed colleagues such as Kei Yamana and Eiji Ochiai. Their combined expertise contributes to the advancement of research in protein applications and therapeutic solutions.
Conclusion
Hitoshi Wada's contributions to protein research highlight his role as an influential inventor in the medical field. His innovative patents and collaborations pave the way for new treatments that could significantly improve patient outcomes.